Elicera Therapeutics includes the first patient in the Phase I/II clinical study CARMA targeting B-cell lymphoma November 5, 2024
New Phase III READY-4 Data Demonstrate Long-Term Safety and Efficacy of Galderma’s RelabotulinumtoxinA (Relfydess™) October 21, 2024
CISCE to introduce non-retaining digital assessment for Classes III, V and VIII: Who will benefit from this and how? October 8, 2024
Internet services in Assam suspended for 8 hours today due to government Grade III recruitment exam September 29, 2024
